ATRION CORPORATION (ATRI) Stock Price & Overview

NASDAQ:ATRI • US0499041053

Current stock price

459.92 USD
+0.26 (+0.06%)
Last:

The current stock price of ATRI is 459.92 USD. Today ATRI is up by 0.06%. In the past month the price increased by 0.48%. In the past year, price increased by 0.88%.

ATRI Key Statistics

52-Week Range274.98 - 503.24
Current ATRI stock price positioned within its 52-week range.
1-Month Range457.5 - 460.26
Current ATRI stock price positioned within its 1-month range.
Market Cap
809.459M
P/E
64.50
Fwd P/E
N/A
EPS (TTM)
7.13
Dividend Yield
1.91%

ATRI Stock Performance

Today
+0.06%
1 Week
+0.10%
1 Month
+0.48%
3 Months
-0.65%
Longer-term
6 Months +31.29%
1 Year +0.88%
2 Years -23.85%
3 Years -33.73%
5 Years -40.82%
10 Years +43.73%

ATRI Stock Chart

ATRION CORPORATION / ATRI Daily stock chart

ATRI Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ATRI. When comparing the yearly performance of all stocks, ATRI is a bad performer in the overall market: 67.28% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ATRI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ATRI. ATRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATRI Earnings

Next Earnings DateNov 5, 2024
Last Earnings DateAug 5, 2024
PeriodQ2 / 2024
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

ATRI Forecast & Estimates


Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ATRI Groups

Sector & Classification

Index Membership

ATRI Financial Highlights

Over the last trailing twelve months ATRI reported a non-GAAP Earnings per Share(EPS) of 7.13. The EPS decreased by -53.54% compared to the year before.


Income Statements
Revenue(TTM)181.60M
Net Income(TTM)12.56M
Industry RankSector Rank
PM (TTM) 6.92%
ROA 4.82%
ROE 5.26%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-93.89%
Sales Q2Q%11.25%
EPS 1Y (TTM)-53.54%
Revenue 1Y (TTM)6%

ATRI Ownership

Ownership
Inst Owners1.01%
Shares1.76M
Float960.00K
Ins Owners1.03%
Short Float %N/A
Short RatioN/A

ATRI Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
MDLN MEDLINE INC-CL A27.7854.466B
COO COOPER COS INC/THE13.9813.642B
ALGN ALIGN TECHNOLOGY INC14.2711.706B
SOLV SOLVENTUM CORP10.1611.582B
LNTH LANTHEUS HOLDINGS INC14.725.136B
MMSI MERIT MEDICAL SYSTEMS INC16.884.157B
ICUI ICU MEDICAL INC15.213.107B
HAE HAEMONETICS CORP/MASS11.152.784B
XRAY DENTSPLY SIRONA INC7.872.305B
NEOG NEOGEN CORP26.81.977B
UFPT UFP TECHNOLOGIES INC201.572B
STAA STAAR SURGICAL CO133.29937.102M
BVS BIOVENTUS INC - A11.04713.391M

About ATRI

Company Profile

ATRI logo image Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.

Company Info

IPO: 1980-03-18

ATRION CORPORATION

One Allentown Parkway

Allen TEXAS 75002 US

CEO: David A. Battat

Employees: 712

ATRI Company Website

Phone: 19723909800

ATRION CORPORATION / ATRI FAQ

What does ATRION CORPORATION do?

Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.


What is the current price of ATRI stock?

The current stock price of ATRI is 459.92 USD. The price increased by 0.06% in the last trading session.


Does ATRION CORPORATION pay dividends?

ATRION CORPORATION (ATRI) has a dividend yield of 1.91%. The yearly dividend amount is currently 8.6.


What is the ChartMill technical and fundamental rating of ATRI stock?

ATRI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is ATRION CORPORATION worth?

ATRION CORPORATION (ATRI) has a market capitalization of 809.46M USD. This makes ATRI a Small Cap stock.


When does ATRION CORPORATION (ATRI) report earnings?

ATRION CORPORATION (ATRI) will report earnings on 2024-11-05, after the market close.